(UroToday.com) In this abstract presented by Alexander Kenigsberg and colleagues, at the American Urologic Association (AUA) annual meeting, the authors evaluated the usage of intravesical chemotherapy in the perioperative setting following radical nephroureterectomy for upper tract urothelial carcinoma. While utilization remains low, they note that usage is increasing worldwide.